An underground market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.
Investigational Drug Gaining Popularity Via Social Media
Retatrutide, which remains in research studies, is being advertised by online personalities for its supposed fat-burning effects. Followers are encouraged to contact these accounts directly for supplier links, while also receiving discount codes.
Active Commerce on Messaging Platforms
Additionally, a flourishing trade exists on Telegram, where groups with thousands of participants share “before and after” photos, administration instructions and assertions of next-day UK delivery. Sellers promote the drug there before directing buyers to other platforms for purchases.
Understanding Retatrutide
This medication is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Professionals Express Worries
However, physicians and pharmacists have warned that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could result in users administering products of unknown origin.
Some experts stated the popularity for retatrutide could be linked to the rising cost of approved slimming products such as Mounjaro.
Legal Position and Enforcement
Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Some influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach pharmaceutical, marketing, and consumer laws, risking fines, legal action or prison.
Platform Reaction and Content Elimination
According to TikTok, the platform has taken down problematic material and banned associated keywords and query recommendations. The company stated it was dedicated to maintaining the platform secure and allocating resources in enhancing compliance measures.
Online Marketplace Operations
Investigations also found communities with up to nine thousand participants selling retatrutide using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately brings up groups with numerous of members, populated with photos of weight loss, glowing testimonials and step-by-step guides for preparing or injecting at home.
After moments of entering one community, a vendor shared contact information, where most purchases take place. The seller provided an guidebook and guaranteed shipping within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about weight, health issues or past usage.
Product Details and Pricing
Within these groups, posts show black plastic parcels with Royal Mail labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at home with sterile water, or pre-filled injectors usually sold at £160 for 20mg. When questioned how much time a injector should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.
Platform Moderation and Safety Measures
A representative for Telegram said it actively moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering materials they can’t verify. Although the research behind this drug is valid, these online versions may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.
Her staff has already encountered patients harmed by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to potentially significant health risks”.
